Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd.

Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. is a wholly state-owned enterprise and a Chinese patent medicine manufacturer under Guangzhou Pharmaceutical Holdings Limited. The factory integrates production and sales of Chinese patent medicines, mainly producing dosage forms such as pills, capsules, granules, dripping pills, and tablets.
Founded in 1600 AD, Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. is a 'China Time-honored Brand' enterprise designated by the State Council. The company is named Chenliji because over four hundred years ago, two ancestors, Chen and Li, jointly established it based on the business philosophy of 'working together to benefit the world,' along with their noble medical ethics and spirit of saving lives. Rooted in such cultural heritage, our factory upholds the business philosophy of 'Four centuries of care, sincere and unwavering.' For over four hundred years, it has made significant contributions to the development of traditional Chinese medicine and the health of the people.
Although Chenliji is an old enterprise, it continuously radiates the vitality of a new-generation company. Through the efforts of several generations, it has now developed into a national key traditional Chinese medicine enterprise with sound economic performance. The production and R&D base was completed in 1997, covering an area of 35,000 square meters. The capsule workshop of Guangzhou Chenliji Pharmaceutical Factory Co., Ltd. obtained national GMP certification in March 2000, passed the on-site inspection by TGA of Australia in November of the same year, obtained national GMP certification for all dosage forms in 2003, and received the Canadian GMP certificate in 2006. The enterprise adopts advanced SAP R/3 and ERP enterprise resource planning systems to improve production efficiency and logistics management.
The four-hundred-year-old golden brand 'Chenliji' itself possesses intangible brand value. It enjoys high visibility both domestically and internationally, especially in South China and Southeast Asia. Its leading products, such as 'Houjiling Capsules,' 'Wuji Baifeng Pills,' 'Zhuangyao Jianshen Pills,' and 'Bupi Yichang Pills,' are sold nationwide and in the Southeast Asian market, earning a reputation for 'authentic ancient prescriptions' at home and abroad. In recent years, the factory has actively implemented technological innovation and brand strategies, dedicating efforts to the research and development of modern traditional Chinese medicine. As a national key project, the specific medicine for rheumatoid arthritis, 'Kunxian Capsules,' has been launched. This product employs advanced macroporous resin extraction technology and holds a considerable market share in the rheumatism and rheumatoid drug market.
Chenliji places great emphasis on human resource development, particularly on the introduction and cultivation of professional talents in various fields. Currently, the enterprise has 219 professional and technical personnel, accounting for over one-third of the total workforce, including 9 with senior professional titles, 49 with intermediate titles, and 35 licensed pharmacists. In terms of education, there are 9 master's degree holders, 85 bachelor's degree holders, and 70 with associate degrees. The enterprise also encourages professionals to pursue higher technical qualifications, providing external knowledge and skills training, as well as appropriate subsidies for middle and senior-level professionals.
Different from other domestic pharmaceutical manufacturers, Chenliji leverages its century-old brand to establish 'Chenliji Pharmaceutical Terminal Sales' across all cities in Guangdong Province, as well as in major cities like Beijing and Shanghai, further strengthening the brand influence.